High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer

Between June 1998 and August 2000, five patients with germ cell tumor were treated with high-dose CEI: carboplatin (1,250 mg/m2), etoposide (1,500 mg/m2), and ifosfamide (7.5 g/m2), followed by peripheral blood stem cell transplantation (PBSCT) at Yokohama City University Hospital. All patients were...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 48(2002), 8 vom: 21. Aug., Seite 469-73
Auteur principal: Hasumi, Hisashi (Auteur)
Autres auteurs: Kishida, Takeshi, Teranishi, Junichi, Nakaigawa, Noboru, Fujinami, Kiyoshi, Ikeda, Ichirou, Uemura, Hiroji, Yao, Masahiro, Takeda, Mitsumasa, Noguchi, Sumio, Kubota, Yoshinobu
Format: Article
Langue:Japanese
Publié: 2002
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Bleomycin 11056-06-7 Granulocyte Colony-Stimulating Factor 143011-72-7 Vinblastine 5V9KLZ54CY Cisplatin Q20Q21Q62J
Description
Résumé:Between June 1998 and August 2000, five patients with germ cell tumor were treated with high-dose CEI: carboplatin (1,250 mg/m2), etoposide (1,500 mg/m2), and ifosfamide (7.5 g/m2), followed by peripheral blood stem cell transplantation (PBSCT) at Yokohama City University Hospital. All patients were classified into either poor risk group of International Germ Cell Consensus Classification or advanced extent of Indiana University stage, and received one cycle of high-dose CEI after 4-6 cycles of standard PEB (cisplatin, bleomycin, vinblastin) therapy. Three of the patients achieved complete response, one achieved partial response and one achieved no change after whole treatment. There were no fatal complications and no treatment-related deaths
Description:Date Completed 19.11.2002
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE
ISSN:0018-1994